Age-related macular degeneration (AMD) is the leading cause of blindness among the
elderly in developed countries. AMD is classified as either neovascular (NV-AMD) or non …

Drug delivery into the vitreous chamber remains a great challenge in the pharmaceutical
industry due to the complex anatomy and physiology of the eye. Intravitreal injection is the …

Purpose To evaluate the long-term clinical and functional outcome, risks, and causes of
vision loss and burden of disease among patients with uveitis. Design Cross-sectional study …

Purpose To identify clinical outcomes and treatment patterns of intravitreal dexamethasone
implant (Ozurdex; Allergan, Inc) in noninfectious uveitis in the clinical setting. Design …

Background The purpose of this study was to evaluate the real-world use, efficacy, and
safety of one or more dexamethasone intravitreal implant (s) 0.7 mg (DEX implant) in …

Electrospinning technique has been explored to produce nanofibers incorporated with drugs
as alternative drug delivery systems for therapeutic purposes in various organs and tissues …

Purpose To report the effectiveness of repeated intravitreal dexamethasone (DEX) inserts in
noninfectious uveitis patients. Design Prospective, single-center, interventional clinical trial …

To investigate the efficacy and safety of dexamethasone (DEX) implant, Ozurdex®, as an
adjunctive treatment for refractory Behçet's uveitis (BU), a total of 61 patients (80 eyes) were …

Uveitis is a spectrum of inflammatory disorders characterized by ocular inflammation and is
one of the leading causes of preventable visual loss. The main aim of the treatment of uveitis …

Macular edema (ME) is the leading cause of visual loss in uveitis and may persist long after
ocular inflammation has been resolved. Local steroids are the first line treatment for uveitis …